Han Shao-Liang, Chen Jun, Zhou Hong-Zhong, Lan Sheng-Hong, Zhang Pei-Chen, Zhu Guan-Bao
Department of General Surgery, First Affiliated Hospital, Wenzhou Medical College, Wenzhou 325000, China.
Hepatobiliary Pancreat Dis Int. 2008 Dec;7(6):638-42.
Some patients with chronic pancreatitis (CP) may require surgery mainly because of intractable pain, suspicion of malignancy, or complications related to CP. This study aimed to analyze the efficacy of surgical treatment for patients with CP in terms of pain relief, control of local complications, and pancreatic endocrine/exocrine function.
Twenty-six patients with CP were treated surgically at our hospital from June 1985 to November 2005. The clinical data of these patients were analyzed retrospectively.
The follow-up time ranged from 8 to 130 months with a median of 60.6 months. No patients were lost to follow-up. All patients had improvement of clinical symptoms such as abdominal pain, steatorrhea and weight loss, to some degree, especially pain relief in patients with good dilation and high pressure of the main pancreatic duct. The endocrine and exocrine functions were not alleviated in all patients, otherwise the impaired glucose tolerance was improved in 8 (30.8%), 15 (57.7%) maintained the same body weight, one (3.8%) had an acute attack of CP, and 2 (7.7%) developed pancreatic carcinoma in the 16th and 28th month postoperatively and died within 3 years after operation for CP. The 1-, 3-, 5-year pain-free rates of CP patients were 96.2% (25/26), 88.5% (23/26) and 84.6% (22/26), respectively.
In selected patients with CP, surgical treatment is a safe procedure and can effectively relieve pain and control local complications; also, it is helpful to improve the quality of life for patients with pancreatitis, and to control the development of this disease.
一些慢性胰腺炎(CP)患者可能需要手术治疗,主要原因是顽固性疼痛、怀疑恶变或与CP相关的并发症。本研究旨在分析CP患者手术治疗在缓解疼痛、控制局部并发症以及胰腺内分泌/外分泌功能方面的疗效。
1985年6月至2005年11月,我院对26例CP患者进行了手术治疗。对这些患者的临床资料进行回顾性分析。
随访时间为8至130个月,中位数为60.6个月。无失访患者。所有患者的腹痛、脂肪泻和体重减轻等临床症状均有不同程度改善,尤其是主胰管扩张良好且压力高的患者疼痛缓解明显。并非所有患者的内分泌和外分泌功能均得到改善,8例(30.8%)糖耐量受损情况有所改善,15例(57.7%)体重维持不变,1例(3.8%)术后第16个月发生CP急性发作,2例(7.7%)术后第16个月和第28个月发生胰腺癌,并在术后3年内因CP死亡。CP患者1年、3年、5年无痛率分别为96.2%(25/26)、88.5%(23/26)和84.6%(22/26)。
对于选定的CP患者,手术治疗是一种安全的方法,能有效缓解疼痛和控制局部并发症;还有助于提高胰腺炎患者的生活质量,并控制疾病发展。